The independent source for health policy research, polling, and news.
2,521-2,540 of 3,715 results
A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine.
Obesity prevention does not get much attention in Colorado, often billed as the healthiest state. Yet more than 1 in 4 black or Hispanic residents are obese, as state and federal public health spending fuels other needs.
Amid forecasts for increasingly unhealthy air due to wildfire smoke, residents in Western states are snatching up home air purifiers. With good reason.
Studies long have linked urban firefighters’ on-the-job exposure to toxins with an increased risk of cancer. More recently, as urban-style development reaches into once remote stretches of California’s mountains and forests, wildfire crews are exposed to fuels and carcinogens more typical of urban fires. We talk with Tony Stefani of the San Francisco Firefighters Cancer Prevention Foundation about the health risks that poses for firefighters.
So-called red flag laws that let police take guns away from people with mental illness have support from both advocates and opponents of gun control. But it won’t alleviate gun violence.
Kelley Watson Snyder, a mother who for years opposed mandatory childhood vaccinations and joined with like-minded parents who espoused similar views, today runs a pro-vaccination Facebook page. What changed?
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Colorado is on the front lines in dealing with how marijuana use affects surgery. Lessons learned on operating tables and in recovery rooms have prompted calls for more research on marijuana nationwide.
Fitness trackers took off about a decade ago, and it’s not unusual for devoted walkers to log several miles a day. But is such a feat necessary?
A KHN review of dozens of inspection reports filed over the past year by the Nakamoto Group reveals disturbing patterns about the company’s audits, including a general willingness to accept accounts of the facilities that the company is paid to scrutinize, and to discount detainees’ complaints.
Geriatricians are outraged over a new requirement to pay for training in order to administer the MoCA test, a widely used tool to screen for cognitive problems. The test’s creator said he was worried about accuracy and liability.
Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.
Amazon, along with a host of other technology companies, is working on ways to use its smart speaker devices to bring a range of health care services into your home.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
A growing number of pregnant women are among the migrants seeking asylum in the United States. Many must wait in Mexico until their cases are heard, spending weeks or months in migrant shelters with limited access to health care.
CBS This Morning covers the highest KHN-NPR Bill of the Month yet: more than half a million dollars for just 14 weeks of kidney dialysis in Montana.
Patients with Type 2 diabetes are often steered toward medicine or insulin treatment. But with additional support, it’s possible to use diet and exercise to control blood sugar. The rising price of insulin drives patients to lower their dependence on the medicine.
Electronic health records can help reduce medical errors, but when not used well they can strain the doctor-patient relationship. Dr. Wei Wei Lee, an internist with the University of Chicago Medicine, has developed strategies to make sure tech is a tool, not a barrier.
Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.
Eighteen years ago, most first responders were not thinking about their future health when they spent hours searching “The Pile” for the remains of terror victims. Today, their illnesses are a slow-moving epidemiological nightmare that has been as difficult for scientists to study as it has been easy for politicians to overlook.
© 2026 KFF